is metformin a glp-1 receptor agonist and Glucagon-like peptide-1 (GLP-1) inhibit Adenosine Figure 17, Pooled mean between-group

Seino Y, Yabe D, Sasaki T, et al

Synaptic alterations and immune response are sexually dimorphic in a non-pertussis toxin model of experimental autoimmune encephalomyelitis

Accordingly, efforts to lower cholesterol to mitigate cardiovascular risk should be paired with measures to reduce other risk factors such as inflammation, oxidation, hypertension, excess plasma glucose, excess body weight, excess fibrinogen, excess homocysteine, low vitamin K, insufficient vitamin D, hormone imbalance, etc

The slowed gastric emptying and altered motility patterns associated with GLP-1 therapy often manifest as bloating, abdominal distention, and early satiety

Exosomes as novel delivery systems for application in traditional Chinese medicine

Chen 2012